NEAR-INFRARED FLUORESCENCE (NIRF) WHOLE BODY AND INTRA-ARTERIAL MOLECULAR IMAGING OF OXIDIZED LDL IN EXPERIMENTAL ATHEROSCLEROSIS  by Khamis, Ramzi et al.
Young Investigator Awards Competition
A2150
JACC April 1, 2014
Volume 63, Issue 12
neAr-inFrAred Fluorescence (nirF) whole body And intrA-ArteriAl MoleculAr iMAging 
oF oxidized ldl in experiMentAl Atherosclerosis
Oral Contributions
Room 147 B
Sunday, March 30, 2014, 11:00 a.m.-11:15 a.m.
Session Title: Young Investigator Awards Competition: Physiology, Pharmacology, and Pathology
Abstract Category: Physiology, Pharmacology, Pathology
Presentation Number: 926-06
Authors: Ramzi Khamis, Kevin Woollard, Gareth Hyde, Tetsuya Hara, Adam Mauskapf, David Granger, Jason Johnson, Vasilis Ntziachristos, Paul M. 
Matthews, Farouc Jaffer, Dorian Haskard, National Heart and Lung Institute, Imperial College, London, United Kingdom, Harvard Medical School, 
Boston, MA, USA
background: Specific imaging of oxidized LDL in atherosclerosis could provide new approaches to detect vulnerable plaques at risk of rupture.
Methods: To image oxidized LDL we generated LO1, an IgG3 monoclonal antibody against MDA-LDL, and labelled it without loss of function with a 
NIR fluorochrome (excitation 750nm). Conjugated LO1 (LO1-750) or control IgG3 (IgG3-750) were injected intravenously. Distribution in wild-type 
(WT) and LDL receptor deficient (LDLR-/-) atherosclerotic mice was detected by noninvasive IVIS Spectrum or Fluorescence Molecular Tomography 
(FMT) combined with micro-CT. To image oxidized LDL in coronary sized vessels, a custom-built 2.9-F rotational, automated pullback intra-arterial 2D 
NIRF catheter with 360o viewing capability was used to localise LO1-750 in atheroma in rabbit aortae, along with IVUS for co-registering of plaque 
morphology.
results: Immunohistochemistry (IHC) showed LO1reactivity with antigen in lipid-rich regions of human, mouse and rabbit atherosclerotic tissue. 
In mice, both IVIS and FMT imaging showed LO1-750 localised in the aortic arch in LDLR-/- but not in WT mice. No aortic uptake was seen 
using control IgG3-750. LO1-750 imaging had superior specificity in aortic regions of interest (ROIs) compared with a co-injected MMP probe 
(MMPSense-645 FAST). A progression study showed significantly greater aortic uptake of LO1-750 in mice fed a high-fat (HF) diet for 42 weeks 
versus 12 weeks (p=0.03) or age-matched mice fed HF for 30 weeks and then chow for 12 weeks. IHC on en face aortic preparations from mice 
coinjected with differentially labelled LO1 and anti-CD31 showed that LO1had localised in macrophage-rich areas beneath endothelium. We 
molecularly expressed a cysteine-tagged humanized LO1-Fab construct which behaved in a similar fashion to the native antibody. In the rabbit, 
LO1-750 localisation was identified in vivo by the intra-arterial NIFR catheter and IVUS, and ex vivo by IHC, in lesional but not healthy regions of the 
aorta.
conclusion: We demonstrate that oxidized LDL can be optically and specifically imaged in vivo using the novel LO1-based NIRF agents, providing 
the groundwork for future detection of vulnerable plaque in patients.
